Aim. To analyze modern treatment methods for achalasia based on esophageal high-resolution manometry data. High-resolution manometry is the «gold standard» in the diagnosis of achalasia. In Chicago Classification of Esophageal Motility Disorders, achalasia divided into three clinically relevant subclasses based on the pattern of contractility in the esophageal body. Different types of esophageal motility disorders in patients with achalasia are essential to determine the prognosis of disease. The most favorable treatment outcomes are observed in patients with achalasia type II (96%). Treatment effectiveness of the patients with achalasia type I inversely correlates with severity of esophageal dilatation (81%). Traditional approaches (pneumocardial dilatation, Heller myotomy) with correction of the only lower esophageal sphincter in patients with achalasia type III are characterized by moderate efficiency (66%). Development of new methods of minimally invasive endoscopic treatment of achalasia (oral endoscopic myotomy) with myotomy length control significantly improved treatment of spastic achalasia (up to 92%). Conclusion. Esophageal high-resolution manometry in patients with suspected achalasia makes it possible to verify the diagnosis, determine the type of achalasia by the Chicago classification and choose the optimal treatment strategy. Oral endoscopic myotomy, balloon pneumocardial dilatation and Heller myotomy are preferred for achalasia type I and II, oral endoscopic myotomy — for achalasia type III and spastic syndromes (distal esophagospasm, hypercontractive esophagus). Botulinum toxin and drug therapy for achalasia have low efficacy, short-term effect and are indicated only for temporary relief of symptoms in preoperative period.